
How to Build This Generation's Big Pharma Company
Episode 128
Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma company around clinical execution. They discuss Formation Bio’s hub-and-spoke model for acquiring and advancing assets, how AI compresses trial timelines and costs, picking winners, regulatory strategy, and what it would take to move from about 50 approvals a year to many more. They also touch on global competition and why clinical proof still drives value in...
Publisher
Raising Health
Link
raisinghealth.simplecast.com/episodes/formation-bio-halving-the-cost-and-time-of-clinical-trials-with-ai-r96XS9Vy
Published
November 17, 2025
Duration
41 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Andreessen Horowitz, a16z Bio + Health
Raising Health
@raisinghealth
#build #generationsbigpharma #lifesciences
